Image de couverture de livre

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shuai Liu, Shaobo Kang, Na Lin, Wenqi Zhang, Shiwen Wang, Yuqing Ren, Xiaofan Ding, Jianxiu Yu, Ruiyu Xie
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Advanced Science
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The TRIB1–PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma
par: Rui Sun, et autres
Publié: (2026)

Aspartame Increases the Risk of Pancreatic Ductal Adenocarcinoma
par: Jumin Xie, et autres
Publié: (2026)

The Key Role of COA6 in Pancreatic Ductal Adenocarcinoma: Metabolic Reprogramming and Regulation of the Immune Microenvironment
par: Lai Jiang, et autres
Publié: (2025)

Mouth to Bile: Microbiome Shifts in Pancreatic Ductal Adenocarcinoma
par: Joha De Maayer, et autres
Publié: (2026)

Tumor‐Derived LAMB3 Drives Immunosuppressive LRRC15 + Fibroblast Formation During Pancreatic Ductal Adenocarcinoma Development
par: Xuqing Shi, et autres
Publié: (2026)

Assessing Pancreatic Ductal Adenocarcinoma Vascular Invasion: the PDACVI Benchmark
par: Riera-Marín, M., et autres
Publié: (2026)

The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma
par: Ofer N. Gofrit, et autres
Publié: (2025)

Ubiquitination‐Associated Ductal–Fibroblast Crosstalk Shapes Tumor Progression and Prognosis in Pancreatic Ductal Adenocarcinoma
par: Yiping Fu, et autres
Publié: (2026)

pH ‐Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma
par: Albrecht Schwab, et autres
Publié: (2026)

Alpha‐Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma ( PDAC ): A Case Report
par: Kaiwen Zhong, et autres
Publié: (2026)

FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival
par: Nathalie B. Rasko, et autres
Publié: (2025)

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort
par: Giulia Peduzzi, et autres
Publié: (2025)

In Vitro and In Vivo Effects of Melatonin‐Containing Combinations in Human Pancreatic Ductal Adenocarcinoma
par: Laura Zeppa, et autres
Publié: (2024)

Retrospective Cohort Study of Palliative Care Patterns in Advanced Pancreatic Ductal Adenocarcinoma
par: Howe Mao, et autres
Publié: (2026)

Thromboembolic Risks in Pancreatic Ductal Adenocarcinoma: A Review of Anatomical and Clinical Variations
par: Lei Zhang, et autres
Publié: (2026)

Immunohistochemical Classification of High‐Grade Pancreatic Intraepithelial Neoplasia and Ductal Cancerization in Pancreatic Ductal Adenocarcinoma Using p53, SMAD4 , and Mucin Expression
par: Yumi Nozawa‐Yoshimura, et autres
Publié: (2025)

Financial Toxicity of Long‐Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma
par: Hala Muaddi, et autres
Publié: (2024)

Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells
par: Erika Stefàno, et autres
Publié: (2024)

Unleashing a Dual‐Warhead Nanomedicine to Precisely Sensitize Immunotherapy for Pancreatic Ductal Adenocarcinoma
par: Di Zhang, et autres
Publié: (2024)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma: Recapitulating Its Importance and Defining Future Directions
par: Martin Lovecek, et autres
Publié: (2025)

Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherapy
par: Aoi Hayasaki, et autres
Publié: (2026)

Neoadjuvant Therapy‐Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis
par: Xiaofei Zhang, et autres
Publié: (2026)

Epigenetic Activation of the CMTM6‐IGF2BP1‐EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
par: Ying‐Qin Zhu, et autres
Publié: (2024)

RETRACTION: KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion
par: BioMed Research International
Publié: (2025)

PanDx: AI-assisted Early Detection of Pancreatic Ductal Adenocarcinoma on Contrast-enhanced CT
par: Liu, Han, et autres
Publié: (2025)

Synthesis, Characterization, and Computational Studies of Organoselenium Compounds for Bioactivity Assessment Against Pancreatic Ductal Adenocarcinoma
par: Bhaskar Banerjee, et autres
Publié: (2025)

An Insulin‐Exosome‐TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer
par: Zhenyu Li, et autres
Publié: (2026)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
par: William A. Ziaziaris, et autres
Publié: (2024)

Cascade Ultrasonic Cavitation Enables Microbubble–Nanoparticle Hybrid to Broadly Accumulate and Penetrate into Pancreatic Ductal Adenocarcinoma
par: Dequan Ye, et autres
Publié: (2025)

Efficacy and Safety of The Albumin‐Bound Paclitaxel Combined with Anti‐PD‐1 Antibody in Pancreatic Ductal Adenocarcinoma
par: Wenjing Hao, et autres
Publié: (2025)

Positive Feedback Loop of Histone Lactylation‐Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance
par: Xi‐Tai Huang, et autres
Publié: (2025)

Mass Spectrometry‐Driven Proteomic Biomarkers for Serum‐Based Detection of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm‐Associated Invasive Carcinoma
par: HyunGyo Jung, et autres
Publié: (2026)

Multiparametric MRI to Predict Response to Irreversible Electroporation Plus Anti‐ PD ‐1 Immunotherapy in Pancreatic Ductal Adenocarcinoma
par: Qizhen Cao, et autres
Publié: (2025)

DNMT1 ‐Induced Downregulation of CBX7 Inhibits ERK Phosphorylation and Promotes Pancreatic Ductal Adenocarcinoma Progression
par: Haowei Shi, et autres
Publié: (2025)

YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma
par: Pengfei Hu, et autres
Publié: (2024)

Pathomics Signature for Prognosis and CA19‐9 Interception in Pancreatic Ductal Adenocarcinoma: A Real‐Life, Multi‐Center Study
par: Qiangda Chen, et autres
Publié: (2026)

A Case of Pancreatic Ductal Adenocarcinoma in PRSS1 ‐Associated Hereditary Pancreatitis in the Absence of High‐Grade PanIN: Suggestive of Chromothripsis‐Like Tumor Evolution
par: Tomoko Norose, et autres
Publié: (2025)

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway
par: Jiayu Ding, et autres
Publié: (2025)

Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma (Adv. Sci. 21/2025)
par: Chen Zhao, et autres
Publié: (2025)

Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor Microenvironment
par: Sihang Cheng, et autres
Publié: (2026)